Cancer Medicines & Diagnostic Tools

The thesis

Own the cancer-care chain from commercial oncology medicines to tumor profiling and laboratory tools, rather than a broad healthcare or biologics basket. Drug-franchise renewal and increasingly individualized treatment create complementary opportunities for medicine developers and diagnostic providers. The basket combines established cash-generating businesses with specialized testing companies, while retaining exposure to clinical, reimbursement and execution risks.